CMChacha David Mangu

Chacha David Mangu

*This is an algorithmically generated author record based on publicly available information.

Chacha David Mangu has a total of 99 co-authors. Here are the top co-authors by number of shared publications:

  • Nyanda Elias Ntinginya

    National Institute for Medical Research

    4 shared publications
  • Adili Kachima

    Affiliation Ministry of Home Affairs, Prison Authority, Dodoma, Tanzania

    2 shared publications
  • Andrea Rachow

    Affiliations Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany, German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany

    2 shared publications
  • Beatrice Mutayobya

    Affiliation National TB and Leprosy Program, Dodoma, Tanzania

    2 shared publications
  • Christa Kasang

    Affiliation Medical Mission Institute, Wuerzburg, Germany

    2 shared publications
  • Clement Mwakabenga

    Affiliation National Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania

    2 shared publications

Latest Publications

  • Open Access

    Tuberculosis services delivery challenges and their mitigations during the COVID-19 pandemic in Tanzania: A qualitative study

    by Doreen Pamba, Erica Sanga, Wiston William, Happiness Mvungi, Hamimu Omary, Theresia Setebe, Willyhelmina Olomi, Chacha Mangu, Issa Sabi, Robert Balama, et al.

    Objective: To describe challenges posed by COVID-19 on TB commodity supply, care cascade, active case finding, and responses taken by healthcare workers (HCWs) and community health workers (CHWs) during the first year of the pandemic (March 2020 to February 2021). Design: A qualitative descriptive study involving 25 in-depth interviews and 10 focus group discussions conducted in July 2022. Setting: 37 TB treatment facilities were purposively selected from seven regions due to high TB case notifications in 2019 and their provision of TB and COVID-19 services during the first year of the pandemic (March 2020 to February 2021). Participants: Purposive selection of 58 HCWs and 55 CHWs who provided TB services in the first year of the COVID-19 pandemic. Results: HCWs reported unusual stockouts and delayed receipt of GeneXpert cartridges and sputum containers. TB services faced a decline in client attendance, as clients were hesitant to undergo TB screening, sputum sample collection, and contact tracing due to fear of contracting or being diagnosed with COVID-19 and subsequently being quarantined. To mitigate these challenges, HCWs used alternative containers for sputum sample collection, optimized GeneXpert cartridges use by prioritizing GeneXpert testing for TB risk groups, and diagnosed TB by microscopy, chest X-ray, and sputum pooling method. Moreover, they extended drug refill schedules to minimize the risk of contracting COVID-19 in clinics. CHWs used mobile communication for client tracing and focused household visits on TB risk groups. Conclusion: COVID-19 disrupted TB commodity availability and TB treatment-seeking behavior. Adaptations like multi-month drug refills and optimized GeneXpert use, supported the TB healthcare system’s resilience. While these adaptations offer valuable insights for strengthening TB service delivery, their effectiveness and sustainability require further evaluation. Thus, prospective studies could clarify their long-term impact. National Tuberculosis Programs could consider adapting these practices post-pandemic, with appropriate modifications to suit different contexts. STRENGTHS AND LIMITATIONS OF THIS STUDY: The study provides insights into healthcare providers’ TB management experiences during the first year of COVID-19. Purposive sampling provided insights into TB service delivery across diverse healthcare cadres and facilities in high-COVID-19 regions. Triangulation of data collection methods and researchers enhanced credibility by ensuring data consistency and reducing potential bias. Retrospective data collection may have introduced recall bias but mitigated through data triangulation. Focusing on high-COVID-19 regions may limit the transferability of findings to less COVID-19 affected areas with different TB service challenges.

  • Open Access

    New admissions and asymptomatic TB cases seem to fuel TB epidemic in prisons, a cross sectional survey in Tanzania

    by Chacha David Mangu, Petra Clowes, Jan van Den Hombergh, Clement Mwakabenga, Simeon Mwanyonga, Jane Ambindwile, Faith Kayombo, Monica Minja, Samuel Kalluvya, Lisa Gerwing-Adima, et al.

    There is an increased risk for tuberculosis (TB) infection and disease progression in prison settings. TB prevalence in prisons in low- and middle-income countries have been measured to be up to 50 -times higher than in the general population. The aim of the study was to perform active TB screening and estimate the burden of TB in central prisons in Tanzania mainland. We performed TB active case finding in five central prisons, Keko, Segerea, Ukonga, Butimba and Ruanda prison in Tanzania, using the Xpert on early morning or spot sputum sample from inmates and new entries between April 2014 and July 2015. A questionnaire that asked about the symptoms and risk factors for TB was administered before a sputum sample was collected. Out of 13,868 incarcerated individuals tested, 13,763 had valid results. TB prevalence among tested was 1550 per 100,000 population (214/13,763); new admissions contributed to the majority (61.68%) of TB cases, but prevalence was higher among inmates (1.75%) compared to new admissions (1.45%). Ukonga, an urban prison which incarcerates long-term convicted inmates had the highest prevalence of 4.02%. Male gender (OR = 2.51, p<0.001), repeated incarcerations (OR = 2.85, p<0.001), history of TB treatment (OR = 1.78, p = 0.002), TB symptoms (OR = 2.78, p = 0.006) and HIV infection (OR = 2.86, p = 0.002) were associated with positive TB results. New admissions could be the driving force of the TB epidemic in the penitentiary system. However, prison environments remain a major risk factor for developing active TB disease.


  • Open Access

    Detection of Bombali Virus in a Mops condylurus Bat in Kyela, Tanzania

    by Ariane Düx, Sudi E. Lwitiho, Ahidjo Ayouba, Caroline Röthemeier, Kevin Merkel, Sabrina Weiss, Guillaume Thaurignac, Angelika Lander, Leonce Kouadio, Kathrin Nowak, et al.

    Bombali virus (BOMV) is a novel Orthoebolavirus that has been detected in free-tailed bats in Sierra Leone, Guinea, Kenya, and Mozambique. We screened our collection of 349 free-tailed bat lungs collected in Côte d’Ivoire and Tanzania for BOMV RNA and tested 228 bat blood samples for BOMV antibodies. We did not detect BOMV-specific antibodies but found BOMV RNA in a Mops condylurus bat from Tanzania, marking the first detection of an ebolavirus in this country. Our findings further expand the geographic range of BOMV and support M. condylurus’ role as a natural BOMV host.


  • Open Access

    Optimizing delivery strategies for 3HP TB preventive treatment in Tanzania: A qualitative study on acceptability of family approach in HIV care and treatment centers

    by Doreen Pamba, Erica Sanga, Killian Mlalama, Lucas Maganga, Chacha Mangu, Anange Lwilla, Willyhelmina Olomi, Lilian Tina Minja, Issa Sabi, Riziki Kisonga, et al.

    Introduction Tanzania rolled-out a 12-dose, weekly regimen of isoniazid plus rifapentine (3HP) TB preventive treatment in January, 2024. Although 3HP completion rate is generally ≥ 80%, variations exist depending on type of delivery strategy and programmatic setting. Prior to the roll-out, a mixed methods study was conducted to assess whether a family approach involving family member support, SMS reminders and three health education sessions, was acceptable and optimized 3HP uptake and completion. This paper describes acceptability of the family approach among people living with HIV (PLHIV), treatment supporters (TS) and community health workers (CHWs). Methods This was a qualitative descriptive study in 12 HIV care and treatment centers across six administrative regions. We purposively sampled 20 PLHIV, 12 CHWs for in-depth interviews and 23 TS for three focus group discussions held between September to December, 2023. The theoretical framework of acceptability guided thematic-content analysis using a framework approach. Results Participants understood that PLHIV have high risk for active TB and that 3HP provides shortened treatment for TB disease prevention. They reported gaining TB and 3HP knowledge from health education sessions. However, participation of TS in health education sessions was low and many reported expensive transportation costs to clinics. Receiving support from someone close and SMS were perceived as good adherence reminders. The majority reported mild self-limiting side effects but expressed positive attitudes because of the shortened treatment, TB counselling, satisfaction from helping others, alignment with lifestyle and work responsibilities and reduced work burden. Some PLHIV reported difficulties in identifying family members for support thus, chose other close friends or CHWs. Conclusions Delivery of 3HP with support from family members and SMS reminders is widely accepted by CHWs, PLHIVs and TS. Restricting support from only family members was unacceptable and attendance of all three health education sessions by TS may not be feasible.

  • Open Access

    New Admissions and Asymptomatic TB Cases fuel TB Epidemic in Prisons, a Cross Sectional Survey in Tanzania

    by Chacha David Mangu, Petra Clowes, Jan van Den Hombergh, Clement Mwakabenga, Simeon Mwanyonga, Jane Ambindwile, Faith Kayombo, Monica Minja, Samuel Kalluvya, Lisa Gerwing-Adima, et al.

    Background: There is an increased risk for tuberculosis (TB) infection and disease progression in prison settings. TB prevalence in prisons of high and middle/low income countries have been measured to be between 5 and 50 -times higher than in the general population. Methods: We performed TB active case finding in five central prisons, Keko, Segerea, Ukonga, Butimba and Ruanda prison in Tanzania, using the Xpert MTB/RIF ® assay on early morning or spot sputum sample from inmates and new entries between April 2014 and July 2015. Results: Out of 13,868 prisoners tested, 13,763 had valid results. TB prevalence was 1.55% (214/13,763); new admissions contributed to the majority (61.68%) of TB cases, but prevalence was higher among inmates (1.75%) compared to new admissions (1.45%). Ukonga, an urban prison which incarcerates long-term convicted inmates had the highest prevalence of 4.02%. Male gender (OR=2.51, p<0.001), repeated incarcerations (OR=2.85, p<0.001), history of TB treatment (OR=1.78, p =0.002), TB symptoms (OR=2.78, p=0.006) and HIV infection (OR=2.86, p=0.002) were associated with positive TB results. Conclusion: New admissions could be the driving force of the TB epidemic in the penitentiary system. However, prison environments remain a major risk factor for developing active TB disease.


  • Open Access

    Kiwira Virus, a Newfound Hantavirus Discovered in Free-tailed Bats (Molossidae) in East and Central Africa

    by Sabrina Weiss, Lwitiho E. Sudi, Ariane Düx, Chacha D. Mangu, Nyanda Elias Ntinginya, Gabriel M. Shirima, Sophie Köndgen, Grit Schubert, Peter T. Witkowski, Jean-Jacques Muyembe, et al.

    A novel hantavirus, named Kiwira virus, was molecularly detected in six Angolan free-tailed bats (Mops condylurus, family Molossidae) captured in Tanzania and in one free-tailed bat in the Democratic Republic of Congo. Hantavirus RNA was found in different organs, with the highest loads in the spleen. Nucleotide sequences of large parts of the genomic S and L segments were determined by in-solution hybridisation capture and high throughput sequencing. Phylogenetic analyses placed Kiwira virus into the genus Mobatvirus of the family Hantaviridae, with the bat-infecting Quezon virus and Robina virus as closest relatives. The detection of several infected individuals in two African countries, including animals with systemic hantavirus infection, provides evidence of active replication and a stable circulation of Kiwira virus in M. condylurus bats and points to this species as a natural host. Since the M. condylurus home range covers large regions of Sub-Saharan Africa and the species is known to roost inside and around human dwellings, a potential spillover of the Kiwira virus to humans must be considered.


  • Open Access

    Hospital mortality statistics in Tanzania: availability, accessibility, and quality 2006–2015

    by Irene R. Mremi, Susan F. Rumisha, Mercy G. Chiduo, Chacha D. Mangu, Denna M. Mkwashapi, Coleman Kishamawe, Emanuel P. Lyimo, Isolide S. Massawe, Lucas E. Matemba, Veneranda M. Bwana, et al.

    Accurate and reliable hospital information on the pattern and causes of death is important to monitor and evaluate the effectiveness of health policies and programs. The objective of this study was to assess the availability, accessibility, and quality of hospital mortality data in Tanzania. This cross-sectional study involved selected hospitals of Tanzania and was carried out from July to October 2016. Review of hospital death registers and forms was carried out to cover a period of 10 years (2006–2015). Interviews with hospital staff were conducted to seek information as regards to tools used to record mortality data, staff involved in recording and availability of data storage and archiving facilities. A total of 247,976 death records were reviewed. The death register was the most (92.3%) common source of mortality data. Other sources included the International Classification of Diseases (ICD) report forms, Inpatient registers, and hospital administrative reports. Death registers were available throughout the 10-year period while ICD-10 forms were available for the period of 2013–2015. In the years between 2006 and 2010 and 2011–2015, the use of death register increased from 82 to 94.9%. Three years after the introduction of ICD-10 procedure, the forms were available and used in 28% (11/39) hospitals. The level of acceptable data increased from 69% in 2006 to 97% in 2015. Inconsistency in the language used, use of non-standard nomenclature for causes of death, use of abbreviations, poorly and unreadable handwriting, and missing variables were common data quality challenges. About 6.3% (n = 15,719) of the records had no patient age, 3.5% (n = 8790) had no cause of death and ~ 1% had no sex indicated. The frequency of missing sex variable was most common among under-5 children. Data storage and archiving in most hospitals was generally poor. Registers and forms were stored in several different locations, making accessibility difficult. Overall, this study demonstrates gaps in hospital mortality data availability, accessibility, and quality, and highlights the need for capacity strengthening in data management and periodic record reviews. Policy guidelines on the data management including archiving are necessary to improve data.


  • Open Access

    Psychological distress and its relationship with non-adherence to TB treatment: a multicentre study

    by Grant Theron, Jonny Peter, Lynn Zijenah, Duncan Chanda, Chacha Mangu, Petra Clowes, Andrea Rachow, Maia Lesosky, Michael Hoelscher, Alex Pym, et al.

    The successful cure of tuberculosis (TB) is dependent on adherence to treatment. Various factors influence adherence, however, few are easily modifiable. There are limited data regarding correlates of psychological distress and their association with non-adherence to anti-TB treatment. In a trial of a new TB test, we measured psychological distress (K-10 score), TB-related health literacy, and morbidity (TBscore), prior to diagnosis in 1502 patients with symptoms of pulmonary TB recruited from clinics in Cape Town (n = 419), Harare (n = 400), Lusaka (n = 400), Durban (n = 200), and Mbeya (n = 83). Socioeconomic, demographic, and alcohol usage-related data were captured. Patients initiated on treatment had their DOTS cards reviewed at two-and six-months. 22 %(95 % CI: 20 %, 25 %) of patients had severe psychological distress (K-10 ≥ 30). In a multivariable linear regression model, increased K-10 score was independently associated with previous TB [estimate (95 % CI) 0.98(0.09-1.87); p = 0.0304], increased TBscore [1(0.80, 1.20); p <0.0001], and heavy alcohol use [3.08(1.26, 4.91); p = 0.0010], whereas male gender was protective [-1.47(−2.28, −0.62); p = 0.0007]. 26 % (95 % CI: 21 %, 32 %) of 261 patients with culture-confirmed TB were non-adherent. In a multivariable logistic regression model for non-adherence, reduced TBscore [OR (95 % CI) 0.639 (0.497, 0.797); p = 0.0001], health literacy score [0.798(0.696, 0.906); p = 0.0008], and increased K-10 [1.082(1.033, 1.137); p = 0.0012], and heavy alcohol usage [14.83(2.083, 122.9); p = 0.0002], were independently associated. Culture-positive patients with a K-10 score ≥ 30 were more-likely to be non-adherent (OR = 2.290(1.033-5.126); p = 0.0416]. Severe psychological distress is frequent amongst TB patients in Southern Africa. Targeted interventions to alleviate psychological distress, alcohol use, and improve health literacy in newly-diagnosed TB patients could reduce non-adherence to treatment.